Related Experiment Videos
Secondary metabolic changes in fibroblasts from six patients with hereditary lactic acidosis
Journal of Inherited Metabolic Disease
|January 1, 1978
Abstract:
Studies on fibroblasts from patients with lactic acidosis of different causes showed secondary metabolic changes in pathways of glucose metabolism. These secondary changes may be important clues to the diagnosis of the many different types of hereditary lactic acidosis.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Reference intervals for eight enzymes in blood of adult females and males measured in accordance with the International Federation of Clinical Chemistry reference system at 37 degrees C: part of the Nordic Reference Interval Project.
Scandinavian journal of clinical and laboratory investigation·2004
[Diagnoses and increased levels of troponin T among discharged patients].
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2002
[New cardiac markers--clinical benefits in early diagnosis of acute heart disease].
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2001
[Troponins and other biochemical cardiac markers--time for a change].
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2000
Markers of myocardial injury in blood following PTCA: a comparison of CKMB, cardiospecific troponin T and troponin I.
Scandinavian journal of clinical and laboratory investigation·1999
Sarcopenia in Pediatric Intoxication Type Inborn Errors of Metabolism: A Frequent and Underrecognized Condition.
Journal of inherited metabolic disease·2026
Genome Editing for Glycogen Storage Diseases.
Journal of inherited metabolic disease·2026
Results From a Phase 2, Open-Label Study Evaluating the Safety, Tolerability, and Effect on Ataxia of GLM101 in Three Adult Patients With PMM2-CDG.
Journal of inherited metabolic disease·2026
Mitochondrial CLPP in Health and Disease: Mechanisms, Therapeutic Duality and Emerging Opportunities.
Journal of inherited metabolic disease·2026
Phase 3 Randomized Trial Results of DTX401 AAV Gene Therapy for the Treatment of GSDIa.
Journal of inherited metabolic disease·2026
Association between HOMA-IR and coexisting MASLD and type 2 diabetes: Insights from NHANES and network pharmacology.
Therapeutic advances in endocrinology and metabolism·2026
Key Experimental Therapeutics and Knowledge Gaps in Metabolic Dysfunction-Associated Steatohepatitis (MASH).
Drug design, development and therapy·2026
Evaluation of muscle microvascular perfusion in primary mitochondrial disease by contrast-enhanced ultrasound: Feasibility study.
Therapeutic advances in rare disease·2026